6533b831fe1ef96bd129865b
RESEARCH PRODUCT
Differentiation in medulloblastomas: correlation between the immunocytochemical demonstration of photoreceptor markers (S-antigen, rod-opsin) and the survival rate in 66 patients
Walter SchachenmayrHorst-werner KorfM CzerwionkaH BuschO Hoffmannsubject
AdultMalePathologymedicine.medical_specialtyAdolescentgenetic structuresCellular differentiationImmunocytochemistryBiologyPhotoreceptor cellPathology and Forensic MedicinePinealocyteCellular and Molecular NeuroscienceAntigenBiopsymedicineHumansPhotoreceptor CellsAntigensCerebellar NeoplasmsChildEye ProteinsSurvival rateRetrospective StudiesMedulloblastomaArrestinmedicine.diagnostic_testInfantMiddle AgedPrognosismedicine.diseaseeye diseasesmedicine.anatomical_structureChild PreschoolFemalesense organsNeurology (clinical)Retinal PigmentsMedulloblastomadescription
Biopsy specimens of 66 medulloblastomas were investigated by means of S-antigen and rod-opsin immunocytochemistry. The patients were operated between 1969 and 1988 and the medical records were retrospectively evaluated to correlate the immunocytochemical features of the tumors to the course of the disease. S-antigen- and rod-opsin-immunoreactive tumor cells were found in 19 out of 66 cases. Since in the normal non-neoplastic state immunoreactive S-antigen and rod-opsin are restricted to retinal photoreceptors and a class of pinealocytes derived from photoreceptor cells, the occurrence of these proteins in certain tumor cells of medulloblastomas suggests a differentiation of these cells along the photoreceptor cell lineage and allows the identification of a special subtype of medulloblastoma displaying photoreceptor-specific characteristics. This subtype appears to be closely related to retinoblastomas and pineal cell tumors. The incidence of this subtype corresponds to approximately 30% of all medulloblastomas. Correlation between the demonstration of immunoreactive S-antigen and rod-opsin and the course of the disease revealed a 10-year survival rate of 50.6% for patients with medulloblastomas displaying photoreceptor-specific characteristics and maximally 11% for patients suffering from medulloblastomas devoid of these markers. Although the statistical evaluation does not provide a significant result, the estimated P-value of 0.085 indicates a distinct trend toward a better prognosis for patients suffering from medulloblastomas with photoreceptor-specific features. The validity of this trend needs to be proven in further studies with a greater number of patients.
year | journal | country | edition | language |
---|---|---|---|---|
1989-01-01 | Acta Neuropathologica |